First Thyroid Eye Disease Drug Wins Over FDA Panel

]]>(MedPage Today) -- SILVER SPRING, Md.--An FDA advisory committee on Friday overwhelmingly recommended the first non-surgical treatment for thyroid eye disease, teprotumumab, for approval.In a 12-0 vote, members of the Dermatologic and Ophthalmic...